Microsimulation and clinical outcomes analysis support a lower age threshold for use of biological valves.

Stoica, Serban; Goldsmith, Kimberley; Demiris, Nikolaos; Punjabi, Prakash; Berg, Geoffrey; Sharples, Linda; Large, Stephen

Stoica, Serban; Goldsmith, Kimberley; Demiris, Nikolaos; Punjabi, Prakash; Berg, Geoffrey; Sharples, Linda; Large, Stephen.

Affiliation

Stoica S; Bristol Royal Children's Hospital, Bristol, UK.

Heart ; 96(21): 1730-6, 2010 Nov.

Article in En | MEDLINE | ID: mdl-20956488

Subject(s)

Aortic Valve/surgery; Bioprosthesis; Heart Valve Diseases/surgery; Heart Valve Prosthesis; Adult; Age Factors; Aged; Aged, 80 and over; Bioprosthesis/adverse effects; Coronary Artery Bypass; Epidemiologic Methods; Female; Heart Valve Diseases/mortality; Heart Valve Prosthesis/adverse effects; Heart Valve Prosthesis Implantation/adverse effects; Heart Valve Prosthesis Implantation/mortality; Humans; Life Expectancy; Male; Middle Aged; Prosthesis Failure; Sex Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Aortic Valve / Bioprosthesis / Heart Valve Prosthesis / Heart Valve Diseases Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Heart Journal subject: CARDIOLOGIA Year: 2010 Type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google